Incidence of
BRAF mutations in cutaneous melanoma: histopathological and molecular analysis of a Ukrainian population.
Melanoma Manag 2023;
10:MMT64. [PMID:
38221928 PMCID:
PMC10784762 DOI:
10.2217/mmt-2023-0005]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2023] [Accepted: 11/16/2023] [Indexed: 01/16/2024] Open
Abstract
Aim
This study aimed to investigate the incidence of BRAF mutation in cutaneous melanoma in the Ukrainian population with respect to clinical and histopathological data.
Materials & methods
This single-center retrospective cohort study enrolled 299 primary CM with known BRAF status assessed by RT-PCR.
Results
The overall BRAF mutation rate was 56.5% in CM and demonstrated a link with the younger age (p < 0.001), anatomical site (p < 0.001) and histological type of CM (p = 0.022). BRAF-positive CM possessed a slightly higher mitotic rate (p = 0.015) and Breslow thickness (p = 0.028) but did not relate to tumor-infiltrating lymphocytes.
Conclusion
The high rate of BRAF mutations in CM patients in the Ukrainian cohort was associated with superficial spreading histology, higher depth of invasion and proliferation.
Collapse